COLE G BRADLEY sold 23.9% of their position (3.67K shares) of KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC on the open market
Open‑market sale worth $299.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/31/2026ACC: 0001337798-26-000004
Director
Since Jul 2020
-8.17K
Net shares
Net seller
$299.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
8.17K disposed
Non-Derivative Transactions2
Class A Ordinary Share
Direct
Shares
−3.67K
Price / share
$81.43
Trade value
$299.09K
% of position
23.9%
7/29/2026
15.35K→11.67K
Class A Ordinary Share
Direct
Shares
−4.50K
Price / share
—
Trade value
—
% of position
38.6%
7/29/2026
11.67K→7.17K
Total
Net shares
−8.17K
Net value
-$299.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Share Direct | 7/29/2026 | S · Sale | −3.67K | $81.43 | $299.09K | 23.9% | 15.35K | 11.67K |
| Class A Ordinary Share Direct | 7/29/2026 | G · Gift | −4.50K | — | — | 38.6% | 11.67K | 7.17K |
| Total | −8.17K | -$299.09K | ||||||
Derivative Transactions0
No derivative transactions reported